MENU
+Compare
GLAXF
Stock ticker: OTC
AS OF
Dec 17 closing price
Price
$16.92
Change
+$0.60 (+3.68%)
Capitalization
103.73B

GLAXF GSK plc Forecast, Technical & Fundamental Analysis

GLAXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for GLAXF with price predictions
Dec 17, 2024

Momentum Indicator for GLAXF turns negative, indicating new downward trend

GLAXF saw its Momentum Indicator move below the 0 level on December 11, 2024. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 145 similar instances where the indicator turned negative. In of the 145 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GLAXF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

GLAXF broke above its upper Bollinger Band on December 09, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for GLAXF entered a downward trend on December 03, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The Moving Average Convergence Divergence (MACD) for GLAXF just turned positive on November 26, 2024. Looking at past instances where GLAXF's MACD turned positive, the stock continued to rise in of 53 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GLAXF advanced for three days, in of 178 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.403) is normal, around the industry mean (5.632). P/E Ratio (17.361) is within average values for comparable stocks, (48.974). Projected Growth (PEG Ratio) (1.467) is also within normal values, averaging (3.004). Dividend Yield (0.059) settles around the average of (0.164) among similar stocks. P/S Ratio (2.437) is also within normal values, averaging (3.643).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. GLAXF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GLAXF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 75, placing this stock worse than average.

View a ticker or compare two or three
GLAXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published Dividends

GLAXF paid dividends on October 07, 2021

GSK plc GLAXF Stock Dividends
А dividend of $0.23 per share was paid with a record date of October 07, 2021, and an ex-dividend date of August 19, 2021. Read more...
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
N/A
Address
980 Great West Road
Phone
+44 2080475000
Employees
90096
Web
https://www.gsk.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FLAU29.730.03
+0.09%
Franklin FTSE Australia ETF
EQLS21.41-0.02
-0.11%
Simplify Market Neutral Eq Long/Shrt ETF
PHYD51.55-0.08
-0.16%
Putnam ESG High Yield ETF
QQH71.62-0.27
-0.38%
HCM Defender 100 Index ETF
JGRO84.34-0.40
-0.47%
JPMorgan Active Growth ETF

GLAXF and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, GLAXF has been loosely correlated with GSK. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if GLAXF jumps, then GSK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLAXF
1D Price
Change %
GLAXF100%
+3.70%
GSK - GLAXF
37%
Loosely correlated
+1.94%
OPHLY - GLAXF
9%
Poorly correlated
-1.41%
HAWPF - GLAXF
8%
Poorly correlated
N/A
ORINY - GLAXF
6%
Poorly correlated
N/A
GIKLY - GLAXF
5%
Poorly correlated
+2.19%
More

Groups containing GLAXF

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLAXF
1D Price
Change %
GLAXF100%
+3.70%
Pharmaceuticals: Major
industry (57 stocks)
12%
Poorly correlated
-0.93%
Pharmaceuticals
industry (308 stocks)
6%
Poorly correlated
-0.71%